炎症Inflammation · 肺 · 呼吸系统 · NTP ntp-0106
诊断要点:只要存在,肺-炎症(Lung - Inflammation)就应诊断并赋予严重程度分级。
病变描述
肺部炎症是吸入研究中最为常见的病变之一。在NTP研究中,炎症有五个标准类别:急性(急性(acute))、化脓性(化脓性(suppurative))、慢性(慢性(chronic))、慢性活动性(慢性 active)和肉芽肿性(肉芽肿性(granulomatous))。在肺-细胞浸润,组织细胞(Lung - Infiltration Cellular, Histiocyte)及Figure 2)中,主要浸润细胞为中性粒细胞(neutrophil),但也可能存在较少的巨噬细胞(macrophage)和淋巴细胞(lymphocyte)。还可能有水肿(edema)或充血(hyperemia)的证据。中性粒细胞也是Figure 4、Figure 5、Figure 6)中的主要浸润细胞类型,但它们聚集在一起,其中许多已发生退变(化脓性渗出物,化脓性 exudate)。渗出物中还可能存在来自 resident 细胞群和浸润白细胞的细胞碎片、含纤维蛋白(fibrin)的蛋白性液体、较少的巨噬细胞、偶见的淋巴细胞或浆细胞(plasma cell),以及可能的感染因子。肉眼观察时,这些病变以脓液存在为特征。渗出物周围组织可能含有成纤维细胞(fibroblast)、纤维结缔组织(fibrous connective tissue)和混合性炎症细胞,具体取决于病变的慢性程度。淋巴细胞在Figure 8、Figure 9、Figure 10、Figure 11、Figure 12)中占优势。淋巴细胞也在Figure 14、Figure 15、Figure 16、Figure 17)中占优势,但也存在大量中性粒细胞。两种病变均可能含有巨噬细胞。Figure 19、Figure 20)是慢性炎症的另一种形式,但该诊断要求存在大量聚集的、大的、活化的巨噬细胞、上皮样巨噬细胞(epithelioid macrophage)或多核巨细胞(multinucleated giant cell)。在所有形式的炎症中,还可能存在水肿、出血(hemorrhage)、纤维蛋白、蛋白沉积症(proteinosis)、变性(degeneration)或坏死(necrosis)。炎症与细胞浸润的鉴别在于是否存在其他改变,如水肿、出血、变性、坏死或其他组织损伤证据。受试物可能刺激上皮细胞和 resident 巨噬细胞分泌细胞因子(cytokine),从而诱导炎症反应。或者,受试物可能导致组织损伤,继而引起炎症。肺内多个区域可能发生炎症,包括气道(支气管和细支气管)、肺泡或肺泡间隔(间质)、终末细支气管/肺泡管区域(腺泡区域)、血管周围区域和胸膜(pleura)。偶尔,肺内局灶性(focal)、极轻微(minimal)的炎症在小鼠和大鼠中作为背景病变可见(Figure 9、Figure 10),尤其是在胸膜下区域。肺泡组织细胞的小聚集也可作为背景病变见到(见),必须与炎症相鉴别。炎症也可由多种感染因子引起,但在当前饲养管理条件下这些情况罕见。经血流影响肺间质的全身性细菌感染通常产生化脓性肺泡炎(化脓性 alveolitis),而病毒感染倾向于诱导化脓性或单核细胞性血管周围炎症。炎症也可与肺肿瘤相关。
诊断与分级建议(NTP 共识)
只要存在,肺-炎症(Lung - Inflammation)就应诊断并赋予严重程度分级。诊断中应包含部位修饰词(如perivascular、interstitial、bronchial、bronchiolar、pleural或subpleural),以指示病变的位置。此外,诊断中应包含炎症类型(如急性(acute)、慢性(chronic))作为修饰词。如果炎症累及一个以上部位,可省略部位修饰词,并在病理学叙述中明确受累部位。当炎症细胞伴有其他提示炎症的改变时,应使用“炎症”一词,这些改变如血管改变(可能导致出血或水肿)、细胞坏死或变性,或正常结构破坏。被视为炎症过程一部分的病变,如水肿和出血,除非严重程度需要,不必单独诊断,但应在叙述中描述。细胞坏死或变性可能是原发性的,引发炎症反应,也可能是继发于炎症。因此,确定哪个病变(坏死或炎症)是原发性的、哪个是继发性的可能非常困难。病理学家应运用其判断来决定是单独诊断这些病变,还是将这些相关病变合并为单一诊断。如果合并为单一诊断,则应在叙述中全面描述病变的所有组成部分。炎症细胞的小局灶性(focal)聚集,无其他炎症证据(如水肿、出血、细胞肿胀、变性或坏死、肺泡间隔增厚、纤维蛋白沉积),应诊断为“细胞浸润”(infiltration cellular)而非炎症。当作为肿瘤的继发发现存在时,炎症不必单独诊断,但应在病理学叙述中描述。相关链接:肺-细胞浸润,组织细胞(Lung - Infiltration Cellular, Histiocyte)
图谱


英文原文
展开 NTP 官方英文描述与建议
Comment:
Inflammation of the lungs is one of the most common lesions seen in inhalation studies. In NTP studies, there are five standard categories of inflammation: acute, suppurative, chronic, chronic active, and granulomatous. In Lung - Infiltration Cellular, Histiocyte and Figure 2 ), the predominant infiltrating cell is the neutrophil, though fewer macrophages and lymphocytes may also be present. There may also be evidence of edema or hyperemia. The neutrophil is also the predominant infiltrating cell type in, Figure 4 , Figure 5 , and Figure 6 ), but they are aggregated, and many of them are degenerate (suppurative exudate). Cell debris, from both the resident cell populations and infiltrating leukocytes, and proteinaceous fluid containing fibrin, fewer macrophages, occasional lymphocytes or plasma cells, and, possibly, an infectious agent may also be present within the exudate. Grossly, these lesions would be characterized by the presence of pus. The tissue surrounding the exudate may contain fibroblasts, fibrous connective tissue, and mixed inflammatory cells, depending on the chronicity of the lesion. Lymphocytes predominate in, Figure 8 , Figure 9 , Figure 10 , Figure 11 , and Figure 12 ). Lymphocytes also predominate in, Figure 14 , Figure 15 , Figure 16 , and Figure 17 ), but there are also a significant number of neutrophils. Both lesions may contain macrophages., Figure 19 , and Figure 20 ) is another form of chronic inflammation, but this diagnosis requires the presence of a significant number of aggregated, large, activated macrophages, epithelioid macrophages, or multinucleated giant cells. In all forms of inflammation, there may also be edema, hemorrhage, fibrin, proteinosis, degeneration, or necrosis. Inflammation is differentiated from cellular infiltrates by the presence of other changes, such as edema, hemorrhage, degeneration, necrosis, or other evidence of tissue damage. A test agent may stimulate epithelial cells and resident macrophages to secrete cytokines, thus inducing an inflammatory response. Alternatively, a test agent may cause tissue damage, which secondarily results in inflammation. Several compartments within the lung may be inflamed, including the airways (bronchi and bronchioles), the alveoli or alveolar septa (interstitium), the terminal bronchiole/alveolar duct region (acinar region), perivascular areas, and the pleura. Occasionally, focal, minimal inflammation in the lung is seen as a background lesion in mice and rats ( Figure 9 and Figure 10 ), particularly in the subpleural region. Small aggregates of alveolar histiocytes can also be seen (see) as a background lesion and must be differentiated from inflammation. Inflammation can also be caused by a number of infectious agents, but these are rare under current husbandry practices. Systemic bacterial infections affecting the pulmonary interstitium via the bloodstream often produce a suppurative alveolitis, whereas viral infections tend to induce suppurative or mononuclear perivascular inflammation. Inflammation can also be associated with pulmonary neoplasms.
Recommendation:
Whenever present, Lung - Inflammation should be diagnosed and assigned a severity grade. A site modifier (e.g., perivascular, interstitial, bronchial, bronchiolar, pleural, or subpleural) should be included in the diagnosis to indicate the location of the lesion. Also, the type of inflammation (e.g., acute, chronic) should be included in the diagnosis as a modifier. If the inflammation affects more than one site, the site modifier may be omitted and the affected locations identified in the pathology narrative. The term "inflammation" should be used when the inflammatory cells are accompanied by other changes indicative of inflammation, such as vascular changes (which may result in hemorrhage or edema), necrosis or degeneration of cells, or disruption of the normal architecture. Lesions that are considered part of the inflammatory process, such as edema and hemorrhage, need not be diagnosed separately unless warranted by severity but should be described in the narrative. Necrosis or degeneration of cells may be primary, inciting an inflammatory response, or it may be secondary to the inflammation. Therefore, it can be very difficult to determine which lesion (necrosis or inflammation) is primary and which is secondary. The pathologist should use his or her judgment in determining whether to diagnose these lesions separately or to combine these related lesions into a single diagnosis. If they are combined into a single diagnosis, all components of the lesions should be thoroughly described in the narrative. A small, focal accumulation of inflammatory cells with no other evidence of inflammation (e.g., edema, hemorrhage, cell swelling, degeneration, or necrosis, alveolar septal thickening, fibrin deposition), should be diagnosed as "infiltration cellular" rather than inflammation. When present as a secondary finding to a neoplasm, the inflammation need not be diagnosed separately but should be described in the pathology narrative. Related Links: Lung - Infiltration Cellular, Histiocyte
来源与引用
原始条目:https://ntp.niehs.nih.gov/atlas/nnl/respiratory-system/lung/Inflammation
图谱总目录:NTP Nonneoplastic Lesion Atlas。 内容属美国联邦政府作品(公有领域),可引用;引用时请标注来源。
建议引用格式:NTP Nonneoplastic Lesion Atlas. Inflammation (lung). LabSmart 中文版:
https://www.labsmart.cn/ntp/lung-inflammation.html
中文图谱总页(可展开对照全部 595 条):https://www.labsmart.cn/ntp-atlas.html#lung-inflammation